Skip to content

A Clinical Study on the Treatment of Functional Constipation with Time-Interfered Electrical Stimulation

A Clinical Study on the Treatment of Functional Constipation with Time-Interfered Electrical Stimulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000861
Enrollment
Unknown
Registered
2026-04-02
Start date
2026-04-15
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional constipation

Interventions

Temporal Interference Electrical Stimulation Group:Time-Interfered Electrical Stimulation Therapy. Three sessions per week for a total of 5 weeks, receiving 15 treatments in total.
Electroacupuncture Group:Electroacupuncture therapy. 3 sessions per week, for a total of 5 weeks, receiving a total of 15 sessions.
Transcutaneous Electrical Stimulation at Acupuncture Points Group:Transcutaneous electrical acupoint stimulation (TEAS) therapy. Three sessions per week for a total of 5 weeks, with a total of 15 trea
Sham Time Interference Electrical Stimulation Group:Time-modulated electrical stimulation therapy. Administered three times a week over five weeks, totaling 15 sessions.

Sponsors

Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Meets the Rome IV diagnostic criteria for functional constipation (FC); (2) Aged between 18 and 75 years, gender; (3) Does not have severe anxiety, depression, or other mental disorders; (4) Has not taken any medications for constipation in the past 2 weeks; (5) Has not undergone acupuncture treatment for constipation in the past 2 months; (6) Has undergone colonoscopy within the past 2 years, excluding organic intestinal diseases (benign lesions such as melanosis coli and colon polyps <3 in number and with the largest diameter =0.5 cm are eligible); (7) Voluntarily participates in this study and signs the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Secondary constipation due to endocrine, metabolic, or neurogenic causes; (2) Coexisting severe diseases of the cardiovascular, endocrine, or rheumatological and immunological systems, with poor general condition or organ failure; (3) Aphasia, altered mental status, inability to express subjective symptoms, or diagnosed severe mental disorders; (4) Pregnancy, lactation, or plans for pregnancy within the next 3 months; (5) Coagulation disorders or severe allergic conditions; (6) History of colonoscopy within the past 2 years with evidence of organic gastrointestinal disease; (7) Currently participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Complete Spontaneous Bowel Movements (CSBMs);

Secondary

MeasureTime frame
Spontaneous Bowel Movements (SBMs); severity of defecation difficulty, severity of incomplete evacuation, stool consistency.;Self-Rating Anxiety Scale (SAS);Self-Rating Depression Scale Score;Pittsburgh Sleep Quality Index (PSQI);Bowel Function Index;Constipation-Related Symptom Severity Rating Scale;Constipation Patients' Quality of Life Self-Rating Scale;Patient Assessment of Constipation Symptoms;TCM symptom score;Composite Autonomic Symptoms Score -31;Heart Rate Variability;The relevant indicators in serum.;

Countries

China

Contacts

Public ContactWu Qiaofeng

Chengdu University of Traditional Chinese Medicine

30074803@qq.com138 8064 8343

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026